β- and γ-Amino Acids at α-Helical Interfaces: Toward the Formation of Highly 
Stable Foldameric Coiled Coils

Nyakatura, Elisabeth K.; Mortier, Jérémie; Radtke, Vanessa S.; Wieczorek, Sebastian; Araghi, Raheleh Rezaei; Baldauf, Carsten; Wolber, Gerhard; Koksch, Beate

doi:10.1021/ml500361c

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

β- and γ-Amino Acids at α-Helical Interfaces: Toward the Formation of Highly Stable Foldameric Coiled Coils

MPS-Authors

/persons/resource/persons21325

Baldauf, Carsten
Theory, Fritz Haber Institute, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Nyakatura, E. K., Mortier, J., Radtke, V. S., Wieczorek, S., Araghi, R. R., Baldauf, C., Wolber, G., & Koksch, B. (2014). β- and γ-Amino Acids at α-Helical Interfaces: Toward the Formation of Highly Stable Foldameric Coiled Coils. ACS Medicinal Chemistry Letters, 5(12), 1300-1303. doi:10.1021/ml500361c.

引用: https://hdl.handle.net/11858/00-001M-0000-0024-9109-8

要旨

Since peptides are vital for cellular and pathogenic processes, much effort has been put into the design of unnatural oligomers that mimic natural peptide structures, also referred to as foldamers. However, to enable the specific application of foldamers, a thorough characterization of their interaction profiles in native protein environments is required. We report here the application of phage display for the identification of suitable helical environments for a sequence comprising an alternating set of β- and γ-amino acids. In vitro selected sequences show that an increase in the hydrophobic surface area at the helical interface as well as the incorporation of a polar H-bond donor functionality can significantly improve interhelical interactions involving backbone-extended amino acids. Thus, our data provide insight into the principles of the rational design of foldameric inhibitors for protein–protein interactions.